Fred Poordad

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 7

Top Topics

Combination Therapy

Top Venues

Liver international : official journal of the International Association for the Study of the Liver

International journal of hepatology

This page only lists publications with an associated author ORCID identifier.

Publications

Rohit L Loomba, Carl LaCerte, Jeffrey Edwards, Fred Poordad, Eric Lawitz, Lois Lee, Sharon Karan, Sangeeta Sawhney, Mary Erickson, Leigh MacConell, Luna Zaru, Jianfen Chen, Jason Campagna
Safety, pharmacokinetics and pharmacodynamics of obeticholic acid in subjects with fibrosis or cirrhosis from NASH. Liver international : official journal of the International Association for the Study of the Liver 44 (4) (2024)
Rohit L Loomba, Carl LaCerte, Jeffrey Edwards, Fred Poordad, Eric Lawitz, Lois Lee, Sharon Karan, Sangeeta Sawhney, Mary Erickson, Leigh MacConell, Luna Zaru, Jianfen Chen, Jason Campagna
Safety, pharmacokinetics and pharmacodynamics of obeticholic acid in subjects with fibrosis or cirrhosis from NASH. Liver international : official journal of the International Association for the Study of the Liver 44 (4) (2024)
Rohit L Loomba, Carl LaCerte, Jeffrey Edwards, Fred Poordad, Eric Lawitz, Lois Lee, Sharon Karan, Sangeeta Sawhney, Mary Erickson, Leigh MacConell, Luna Zaru, Jianfen Chen, Jason Campagna
Safety, pharmacokinetics and pharmacodynamics of obeticholic acid in subjects with fibrosis or cirrhosis from NASH. Liver international : official journal of the International Association for the Study of the Liver 44 (4) (2024)
Rohit L Loomba, Carl LaCerte, Jeffrey Edwards, Fred Poordad, Eric Lawitz, Lois Lee, Sharon Karan, Sangeeta Sawhney, Mary Erickson, Leigh MacConell, Luna Zaru, Jianfen Chen, Jason Campagna
Safety, pharmacokinetics and pharmacodynamics of obeticholic acid in subjects with fibrosis or cirrhosis from NASH. Liver international : official journal of the International Association for the Study of the Liver 44 (4) (2024)
Rohit L Loomba, Carl LaCerte, Jeffrey Edwards, Fred Poordad, Eric Lawitz, Lois Lee, Sharon Karan, Sangeeta Sawhney, Mary Erickson, Leigh MacConell, Luna Zaru, Jianfen Chen, Jason Campagna
Safety, pharmacokinetics and pharmacodynamics of obeticholic acid in subjects with fibrosis or cirrhosis from NASH. Liver international : official journal of the International Association for the Study of the Liver (2024)
Saatchi Kuwelker, Eugenia Tsai, Lily Kuo, Jae Kim, Timothy Van Frank, Robert Mitchell, Ruben Ramirez, Richard Guerrero, Bryan Hanysak, Carmen Landaverde, Fabian Rodas, Eric Lawitz, Tamneet Basra, Harry Nguyen, Kim Christensen, Clarissa Vaughn, Kim Hinojosa, Nina Olvera, Edna Caraballo-Gonzalez, Emma Pham, Lisa D Pedicone, Fred Poordad
High sustained virologic response rates, regardless of race or socioeconomic class, in patients treated with chronic hepatitis C in community practice using a specialized pharmacy team. Medicine 102 (30) (2023)
Fred Poordad, Norah A Terrault, Naim Alkhouri, Wei Tian, Lee F Allen, Mordechai Rabinovitz
Avatrombopag, an Alternate Treatment Option to Reduce Platelet Transfusions in Patients with Thrombocytopenia and Chronic Liver Disease-Integrated Analyses of 2 Phase 3 Studies. International journal of hepatology 2020 (2020)